drugset / Trial / NCT05214196
The Efficacy of Oral Antiseptics Against COVID-19
RandomizedParallel-groupTriple-blindSupportive care
Summary
In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypochlorous acid | Other / unclassified | 0.02 % | Oral |
| Subject | Hypochlorous acid | Other / unclassified | 20 ml | Oral |
| Subject | Povidone-Iodine | Other / unclassified | 0.5 % | Oral |
| Subject | Povidone-Iodine | Other / unclassified | 20 ml | Oral |